Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
In addition, experimental models of HE suggest that ammonia-related neurotoxicity may extend beyond astrocytic dysfunction to impaired hippocampal synaptic plasticity [32]
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)
Mioduchoski, FNP-BC This treatment is ideal for: If youve been previously searching for BPC-157 near me in Palm Beach, our clinic provides safe, effective, and doctor-supervised solutions that truly work
These medications are included in the GLP-1 receptor agonist family of drugs
Low zinc, poor ceruloplasmin production or impaired biliary copper excretion may worsen copper-related oxidative stress
